(Q48570612)

English

Factors influencing a patient's decision regarding riluzole: an early experience

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

title

Factors influencing a patient's decision regarding riluzole: an early experience (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

author name string

S A Rudnicki

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

publication date

1 October 1997

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

published in

Journal of the Neurological Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

volume

152 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

page(s)

S80-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

cites work

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900250-5

retrieved

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900250-5

retrieved

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900250-5

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0022-510X(97)00250-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

PubMed publication ID

9419060

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9419060

retrieved

12 February 2018

reference URL

http://europepmc.org/abstract/MED/9419060

(Q48570612)

Factors influencing a patient's decision regarding riluzole: an early experience

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)